Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Transplant Proc ; 43(4): 1196-7, 2011 May.
Article in English | MEDLINE | ID: mdl-21620087

ABSTRACT

Type 1a glycogen storage disease (GSD 1a), or von Gierke disease, is a rare, autosomal-recessive disease caused by a deficiency of glucose-6-phosphatase, which leads to glycogen accumulation in the liver, kidney, and intestinal mucosa. Clinical manifestations include hypoglycemia, growth retardation, hepatomegaly, lactic acidemia, hyperlipidemia, and hyperuricemia. Long-term complications include renal disease, gout, osteoporosis, pulmonary hypertension, short stature, and hepatocellular adenomas, which may undergo malignant transformation. Herein we have described the management and the clinical course of a GSD1a patient who underwent simultaneous preemptive liver- kidney transplantation (SPLKT), which solved the liver and renal disease. We confirmed the rapid normalization of glucose metabolism, and correction of hyperlipemia after liver transplantation. In our opinion uremic patients with GSD 1a with or without adenomas must be considered for SPLKT. To our knowledge this is the fifth case of SPLKT and the first preemptive one to be described in the literature.


Subject(s)
Adenoma, Liver Cell/surgery , Glomerulosclerosis, Focal Segmental/surgery , Glycogen Storage Disease Type I/surgery , Kidney Transplantation , Liver Neoplasms/surgery , Liver Transplantation , Adenoma, Liver Cell/etiology , Adult , Disease Progression , Female , Glomerulosclerosis, Focal Segmental/etiology , Glycogen Storage Disease Type I/complications , Humans , Liver Neoplasms/etiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...